Pandemic Accord, Tightened Budget On Menu At World Health Organisation Meet
Next week promises to be a crucial one for the World Health Organization, with member states coming together in Geneva to adopt a landmark pandemic agreement and a slimmed-down budget amid US funding cuts.
Dozens of high-ranking officials and thousands of delegates are set to gather for the United Nations health agency's annual decision-making assembly, due to last from May 19 to 27.
"This huge gathering comes... at a pivotal moment for global health," Catharina Boehme, WHO's assistant director-general for external relations and governance, told reporters.
It comes as countries are confronting "emerging threats and major shifts in the landscape for global health and international development", she said.
More than five years after the emergence of Covid-19, which killed millions of people, much of the focus next week will be on the expected adoption of a hard-won international agreement on how to better protect against and tackle future pandemics.
After more than three years of negotiations, countries reached consensus on a text last month but final approval by the World Health Assembly is needed -- a discussion expected to take place on Tuesday.
'Without The US'
The United States, which has thrown the global health system into crisis by slashing foreign aid spending, was not present during the final stretch of the talks.
US President Donald Trump ordered a withdrawal from the WHO and from the pandemic agreement talks after taking office in January.
The agreement "is a jab in the arm for multilateralism, even if it is multilateralism in this case without the US", said a European diplomat who asked not to be named.
The WHA will be called upon to ratify the adoption of the agreement and to launch an intergovernmental working group to negotiate technical details of the so-called Pathogen Access and Benefit-Sharing System (PABS), said negotiations co-chair Anne-Claire Amprou.
Core to the agreement, that system will be aimed at allowing the swift sharing of pathogen data with pharmaceutical companies, enabling them to quickly start working on pandemic-fighting products.
Once the PABS annex is completed and adopted at the 2026 WHA, "the whole (agreement) will open for signature", Steven Solomon, WHO's principal legal officer, told reporters.
Ratification by 60 states will be needed for the accord to come into force.
Deep Cuts
Also high on the agenda next week will be the dramatic overhaul of WHO operations and finances.
WHO chief Tedros Adhanom Ghebreyesus told member states last month that the agency would need to slim down due to deep US funding cuts.
The agency has been bracing for Trump's planned full withdrawal of the United States -- by far its largest donor -- next January.
The United States gave WHO $1.3 billion for its 2022-2023 budget, mainly through voluntary contributions for specific projects rather than fixed membership fees.
"The loss of US funding, combined with reductions in official development assistance by some other countries, mean we are facing a salary gap for the next biennium of more than $500 million," Tedros said on Wednesday.
Tedros has not said how many jobs will be lost, but on Wednesday he announced the organisation would cut its leadership team nearly in half.
Budget Gap
Next week, member states will vote on a proposed 20-percent increase of WHO's mandatory membership fees for the 2026-27 budget period, Boehme said.
Members already agreed in 2022 to increase the mandatory fees to cover 50 percent of the WHO budget.
Without that decision, Tedros said Wednesday that "our current financial situation would be much worse -- $300 million worse".
"It is essential, therefore, that member states approve this next increase, to make another step towards securing the long-term financial sustainability and independence of WHO."
Countries will also be asked to adopt the 2026-2027 budget, at a time when development assistance funding, including for health resources, are dwindling globally.
"We have proposed a reduced budget of $4.2 billion for the 2026-2027 biennium, a 21-percent reduction on the original proposed budget of 5.3 billion," Tedros said.
If the increase in membership fees is approved, the WHO estimates it can raise more than $2.6 billion, or more than 60 percent of the budget.
"That leaves an anticipated budget gap of more than $1.7 billion," Tedros said.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
27 minutes ago
- Time of India
Rise in COVID-19 Cases: 7 essential medical gadgets for home use
Covid cases India India is witnessing a resurgence of COVID-19 cases , with active infections now exceeding 1,000. This means, it becomes all the more essential for you to have regular health checkups and keep certain essential medical gadgets handy at home to monitor vital signs . Collecting personal health data can aid in quicker diagnosis and treatment. Several low-cost devices are available to track vitals like blood pressure, blood oxygen levels, respiration rate and pulse rate. Daily tracking can provide insights into personal health trends and help doctors detect irregularities early. Stay ready with these 7 essential medical gadgets as COVID cases rise Before you buy: Doctor's consultation recommended Before listing them, it is highly recommended to consult a doctor for advice on selecting suitable medical gadgets for personal use. All treatment, medication, and symptom tracking should be discussed with a medical professional. It is also important to note that this information is for general awareness of available devices and does not recommend specific brands or provide medical advice. Always consult your doctor or a medical professional regarding correct usage, accuracy and potential interference with other medical devices like pacemakers. Here are some essential medical gadgets to consider amid rise in Covid cases Contactless IR Thermometer: This device is crucial for quickly checking body temperature without physical contact. Consult a medical professional for model recommendations. Automatic Electronic Blood Pressure Monitor : An essential gadget for monitoring blood pressure and, ideally, pulse rate. Seek medical advice for suitable device recommendations. Fingertip Pulse Oximeter : A small, affordable device that measures blood oxygen saturation and pulse rate by simply inserting an index finger. Glucometer: Used to measure blood glucose levels. Portable Personal ECG Monitor: These devices, often with smartphone companion apps, allow for daily ECG recordings, providing vital information for doctors to detect heart irregularities early. Medical Alert System: Particularly useful for elders, these systems allow users to call for help with the press of a button during an emergency, offering a simpler alternative to finding and dialing a phone. Pain Relief Devices: Various devices like hot pads, massagers, or nerve stimulators can offer at-home pain relief. Consult your doctor to select the appropriate device for your needs. AI Masterclass for Students. Upskill Young Ones Today!– Join Now
NDTV
an hour ago
- NDTV
WHO Is Finalising A New Treaty To Prep For The Next Pandemic, But US Isn't Signing
On March 20, 2025, members of the World Health Organization adopted the world's first pandemic agreement, following three years of 'intensive negotiations launched by governments in response to the devastating impacts of the COVID-19 pandemic.' The U.S., however, did not participate, in part because of its intention to withdraw from the WHO. Global health experts are hailing the agreement as a historic moment. What does the agreement mean for the world, and how can it make everyone safer and more prepared for the next pandemic? The Conversation asked Nicole Hassoun, a professor at Binghamton University and executive director of Global Health Impact, to explain the pandemic accord, its prospects for advancing global health, and the significance of the U.S.'s absence from it. What will the pandemic agreement do? The accord will bolster pandemic preparation within individual countries and around the world. Countries signing onto the agreement are committing to improve their disease surveillance and grow their heath care workforces, strengthen their regulatory systems and invest in research and development. It encourages countries to strengthen their health regulations and infrastructure, improve communication with the public about pandemics and increase funding for preparation and response efforts. It also includes new mechanisms for producing and distributing vaccines and other essential countermeasures. Finally, it encourages countries to coordinate their responses and share information about infectious diseases and intellectual property so that vaccines and other essential countermeasures can be made available more quickly. The agreement will take effect once enough countries ratify it, which may take several years. Why isn't the US involved? The Biden administration was broadly supportive of a pandemic agreement and was an active participant in negotiations. Prior to Donald Trump's reelection, however, Republican governors had signed a letter opposing the treaty, echoing a conservative think tank's concerns about U.S. sovereignty. The U.S. withdrew from negotiations when President Trump signed an executive order to withdraw from the WHO on the day he was inaugurated for his second term. Why could the lack of US involvement be beneficial for the world? The lack of U.S. involvement likely resulted in a much more equitable treaty, and it is not clear that countries could have reached an agreement had the U.S. continued to object to key provisions. It was only once the U.S. withdrew from the negotiations that an agreement was reached. The U.S. and several other wealthy countries were concerned with protecting their pharmaceutical industry's profits and resisted efforts aimed at convincing pharmaceutical companies to share the knowledge, data and intellectual property needed for producing new vaccines and other essential countermeasures. Other negotiators sought greater access to vaccines and other treatments during a pandemic for poorer countries, which often rely on patented technologies from global pharmaceutical companies. While most people in wealthy countries had access to COVID-19 vaccines as early as 2021, many people in developing countries had to wait years for vaccines. How could the agreement broaden access for treatments? One of the contentious issues in the pandemic agreement has to do with how many vaccines manufacturers in each country must share in exchange for access to genetic sequences to emerging infectious diseases. Countries are still negotiating a system for sharing the genetic information on pathogens in return for access to vaccines themselves. It is important that researchers can get these sequences to make vaccines. And, of course, people need access to the vaccines once they are developed. Still, there are many more promising aspects of the agreement for which no further negotiations are necessary. For instance, the agreement will increase global vaccine supply by increasing manufacturing around the world. The agreement also specifies that countries and the WHO should work together to create a mechanism for fairly sharing the intellectual property, data and knowledge needed to produce vaccines and other essential health products. If financing for new innovation requires equitable access to the new technologies that are developed, many people in poor countries may get access to vaccines much more quickly in the next pandemic. The agreement also encourages individual countries to offer sufficient incentives for pharmaceutical companies to extend access to developing countries. If countries implement these changes, that will benefit people in rich countries as well as poor ones. A more equitable distribution of vaccines can contain the spread of disease, saving millions of lives. What more should be done, and does the US have a role to play? In my view, the best way to protect public health moving forward is for countries to sign on to the agreement and devote more resources to global health initiatives. This is particularly important given declining investment and participation in the WHO and the contraction of other international health initiatives, such as USAID. Without international coordination, it will become harder to catch and address problems early enough to prevent epidemics from becoming pandemics. It will also be imperative for member countries to provide funding to support the agreement's goals and secure the innovation and access to new technologies. This requires building the basic health infrastructure to ensure shots can get into people's arms.
Hindustan Times
3 hours ago
- Hindustan Times
Vaccines can cause the disease? Doctor busts 5 myths about vaccination, shares facts
Vaccination is a vital preventive measure that helps protect against potentially life-threatening diseases. It acts as a shield, preparing the body to fight infections effectively. However, widespread misconceptions and misinformation often lead people to hesitate or avoid getting vaccinated, putting their health at risk. Also read | Vaccine misinformation: A lasting side effect from Covid In an interview with HT Lifestyle, Dr. Anusuya Shetty, physician at Apollo Clinic in Koramangala busted several myths associated with vaccines. Fact: Extensive research shows vaccines do not cause autism, and vaccinated children develop autism at the same rate as non-vaccinated children. Numerous big, well-controlled studies involving more than a million children discovered no link between immunizations and autism. The scientific consensus is unequivocal: vaccinations are safe and do not cause autism. Fact: Live vaccines use weakened viruses or bacteria to safely train and strengthen the immune system. These microorganisms do not cause disease, but they do help the body produce antibodies for future protection. Mild symptoms may appear, but they are normally innocuous unless the individual has a weakened immune system. Virus shedding is uncommon and unlikely to infect others; immunisation protects vulnerable individuals. Also read | New vaccine offers broad protection against coronaviruses that haven't even emerged yet: Study Fact: The public can distinguish between legitimate vaccine information and misinformation online by evaluating the source of information, the publication date, and whether the item was written by a competent medical professional. Fact: Vaccine content on social media frequently supports anti-vaccine narratives, which receive more attention than pro-vaccine comments. According to studies, misinformation spreads rapidly, particularly during large events such as disease outbreaks, and is magnified by bots and trolls. These inorganic accounts can establish a misleading equilibrium between pro- and anti-vaccine positions. As a result, social media can amplify misinformation and undermine effective public health messaging. Fact: The flu vaccine cannot give you the flu since it includes a dead virus. Any symptoms, such as a hurting arm or weariness, are transient and unrelated to influenza. The vaccine is completely safe and does not cause disease. Also read | Heart attack cases not rising due to Covid vaccine, but stress and other traditional factors, says cardiologist Note to readers: This article is for informational purposes only and not a substitute for professional medical advice. Always seek the advice of your doctor with any questions about a medical condition.
